327257005: Progestogens in malignant disease (product)
Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2007. Module: SNOMED CT core
Descriptions:
Expanded Value Set
Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Progestogens in malignant disease |
Is a |
hormones, produits de substitution synthétiques et antagonistes |
false |
Inferred relationship |
Some |
|
|
Progestogens in malignant disease |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hormone |
false |
Inferred relationship |
Some |
|
|
Progestogens in malignant disease |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
hormones et leurs métabolites et précurseurs |
false |
Inferred relationship |
Some |
|
|
Progestogens in malignant disease |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
hormone, hormone synthétique de substitution ou hormone antagoniste |
false |
Inferred relationship |
Some |
|
|
Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Reference Sets
Concept inactivation indicator reference set
GB English
US English
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)
Back to Start